Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

Yu X, Liang X, Xie H, Kumar S, Ravinder N, Potter J, de Mollerat du Jeu X, Chesnut JD.

Biotechnol Lett. 2016 Jun;38(6):919-29. doi: 10.1007/s10529-016-2064-9. Epub 2016 Feb 18.

2.

Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis.

Eguchi A, De Mollerat Du Jeu X, Johnson CD, Nektaria A, Feldstein AE.

J Hepatol. 2016 Mar;64(3):699-707. doi: 10.1016/j.jhep.2015.11.002. Epub 2015 Nov 7.

3.

Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells.

Povero D, Eguchi A, Niesman IR, Andronikou N, de Mollerat du Jeu X, Mulya A, Berk M, Lazic M, Thapaliya S, Parola M, Patel HH, Feldstein AE.

Sci Signal. 2013 Oct 8;6(296):ra88. doi: 10.1126/scisignal.2004512.

4.

Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design.

Buyens K, De Smedt SC, Braeckmans K, Demeester J, Peeters L, van Grunsven LA, de Mollerat du Jeu X, Sawant R, Torchilin V, Farkasova K, Ogris M, Sanders NN.

J Control Release. 2012 Mar 28;158(3):362-70. doi: 10.1016/j.jconrel.2011.10.009. Epub 2011 Oct 14. Review.

PMID:
22023849
5.

Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor alpha (PPARalpha) activity.

Gachon F, Leuenberger N, Claudel T, Gos P, Jouffe C, Fleury Olela F, de Mollerat du Jeu X, Wahli W, Schibler U.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4794-9. doi: 10.1073/pnas.1002862108. Epub 2011 Mar 7.

Supplemental Content

Loading ...
Support Center